Does BARICITINIB Cause Neoplasm malignant? 72 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 72 reports of Neoplasm malignant have been filed in association with BARICITINIB (Olumiant). This represents 0.9% of all adverse event reports for BARICITINIB.
72
Reports of Neoplasm malignant with BARICITINIB
0.9%
of all BARICITINIB reports
6
Deaths
7
Hospitalizations
How Dangerous Is Neoplasm malignant From BARICITINIB?
Of the 72 reports, 6 (8.3%) resulted in death, 7 (9.7%) required hospitalization, and 3 (4.2%) were considered life-threatening.
Is Neoplasm malignant Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BARICITINIB. However, 72 reports have been filed with the FAERS database.
What Other Side Effects Does BARICITINIB Cause?
Drug ineffective (569)
Off label use (479)
Covid-19 (347)
Pulmonary embolism (288)
Rheumatoid arthritis (284)
Headache (216)
Herpes zoster (216)
Pneumonia (216)
Death (206)
Deep vein thrombosis (201)
What Other Drugs Cause Neoplasm malignant?
RANITIDINE (10,648)
ADALIMUMAB (2,028)
APIXABAN (1,772)
ETANERCEPT (1,616)
METHOTREXATE (1,041)
TOFACITINIB (1,020)
RITUXIMAB (929)
INFLIXIMAB (892)
ABATACEPT (727)
RISANKIZUMAB-RZAA (715)
Which BARICITINIB Alternatives Have Lower Neoplasm malignant Risk?
BARICITINIB vs BARIUM
BARICITINIB vs BARNIDIPINE
BARICITINIB vs BASILIXIMAB
BARICITINIB vs BAYER GENUINE ASPIRIN ORIGINAL STRENGTH
BARICITINIB vs BAZEDOXIFENE\ESTROGENS, CONJUGATED